Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Practice Surveillance of the Use of Herceptin in Patients With HER2-positive Advanced Adenocarcinoma of the Stomach or Gastro-esophageal Junction (GEJ) (HERMES)

NCT01220934 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01220934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01220934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Practice Surveillance of the Use of Herceptin in Patients With HER2-positive Advanced Adenocarcinoma of the Stomach or Gastro-esophageal Junction (GEJ) (HERMES)
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
April 16, 2010
Completion date
June 1, 2016
Enrollment
443 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer